Abbot Financial Management, Inc.
Abbot Financial Management, Inc. latest Q1_2021 13F filings reported $220,402,000 in market value on this 2021-05-13 report date . The portfolio quarterly return is 28.02%. This fund has 133 securities concentrations of 100% weights.
Abbot Financial Management, Inc. largest holding is Rubius Therapeutics Inc. with weight of 17.01% and $37,484,000 in market value. The portfolio return is computed based on the amount invested in the new quarter. The following shows the portfolio details.
Portfolio Performance History
| FILE DATE | REPORT PERIOD | QTR YEAR | FILE TYPE | NOS. OF STOCKS | REPORTED VALUE | RETURN |
|---|---|---|---|---|---|---|
| 2021-05-13 | 2021-03-31 | Q1_2021 | 13F-HR | 133 | $220,402,000 | 28.02% |
| 2021-02-11 | 2020-12-31 | Q4_2020 | 13F-HR | 128 | $172,165,000 | 12.68% |
| 2020-10-26 | 2020-09-30 | Q3_2020 | 13F-HR | 119 | $152,794,000 | 6.54% |
| 2020-07-22 | 2020-06-30 | Q2_2020 | 13F-HR | 117 | $143,420,000 | 18.72% |
| 2020-05-12 | 2020-03-31 | Q1_2020 | 13F-HR | 108 | $120,805,000 | -22.88% |
| 2020-02-12 | 2019-12-31 | Q4_2019 | 13F-HR | 123 | $156,648,000 | 12.75% |
| 2019-11-13 | 2019-09-30 | Q3_2019 | 13F-HR | 116 | $138,938,000 | 1.30% |
| 2019-08-08 | 2019-06-30 | Q2_2019 | 13F-HR | 117 | $137,155,000 | 7.28% |
| 2019-05-15 | 2019-03-31 | Q1_2019 | 13F-HR | 105 | $127,848,000 | 13.42% |
| 2019-02-07 | 2018-12-31 | Q4_2018 | 13F-HR | 100 | $112,725,000 | -15.87% |
| 2018-11-09 | 2018-09-30 | Q3_2018 | 13F-HR | 110 | $133,996,000 | 6.95% |
| 2018-08-09 | 2018-06-30 | Q2_2018 | 13F-HR | 107 | $125,287,000 | 0.79% |
| 2018-05-02 | 2018-03-31 | Q1_2018 | 13F-HR | 105 | $124,307,000 | -0.45% |
| 2018-02-13 | 2017-12-31 | Q4_2017 | 13F-HR | 98 | $124,866,000 | 4.03% |